Navigation Links
Inquiry into Past NHS Treatment Disaster

Bereaved families of persons infected with deadly viruses such as HIV and Hepatitis C decades back, will now get a chance to understand how. //

An independent inquiry is soon to be launched into the contracting of these deadly infections by almost 2000 hemophilia patients, via blood transfusions, in what is acknowledged as the biggest treatment blunder in the history of UK’s National Health Services.

The incident took place in the late 70s and early 80s where out of 4,670 hemophiliacs who received transfusions with donated blood and blood products and exposed to hepatitis C, 1,243 were also exposed to HIV.

Unfortunately, despite improvements in treatment for both viruses, only 2,552 patients with hepatitis C and just 361 with HIV are alive today.

Says Labor MP Lord Peter Archer, who is heading the inquiry: “The purpose of the inquiry is to unravel the facts, so far as we are able, and to point to the lessons that may be learnt.

“ Its impact will, however, depend crucially on the public perception of its value and we shall endeavor to make it a report worthy of high regard. Hopefully our findings may help to restore public confidence in the future treatment of patients.

"We trust it will also help those afflicted and bereaved to come to terms with the tragedy - knowing much more of how it came about”, he added.

The events, which took place between the early 1970s and the mid 1980s, have been described by fertility expert Lord Winston as "the worst treatment disaster in the history of the national health service".

Labor peer Lord Alf Morris, Britain's first minister for disabled people and the present president of the all-party parliamentary group on hemophilia, has been leading the campaign on the patients' behalf.

Hemophilia is a disorder where the blood takes longer time to clot due to the absence or limited amount of one of the proteins essential to clotting.

Former ways of treatment were the transfusions of blood or blood products from pooled blood plasma collections of various donors.

Due the risks of transmission of blood -borne viruses, recent methods are the use of artificially created such proteins.

The Hemophilia Society of UK has welcomed the inquiry.
NN
'"/>




Related medicine news :

1. Kerr Discourages Transfusion Hepatitis Inquiry
2. Inquiry Led In To the Hepatitis B Infection in the Hospitals
3. Advances in Treatment of Cataracts
4. Recommendations for Treatment of Blood Pressue
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Better Treatment for obesity
8. Gene Treatment for Heart Disease
9. More People Seeking Treatment for Depression
10. Focused Treatment For Childhood Cancer
11. Inadequate Drug Treatment For Youth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology: